Mithra Women's Health

The entire Mithra team wishes you all a fun, relaxing and joyous end of year! We look forward to working with you in 2024!

Mithra and Gedeon Richter are proud to announce they have signed binding Head of Terms to commercialize ESTELLE® and DONESTA® in China. For more information we invite you to read our latest press release bit.ly/4a4uiK3

Key to Mithra’s operations is Estetrol (E4). Estetrol is in two of our therapies, Estelle® and Donesta® and it is a natural estrogen. Find out more about Estetrol here: mithra.com/en/estetrol/ #Mithra #biotech #biopharma #ReproductiveHealth #innovation

We are looking forward to presenting at the @European Society of Gynecology Congress on Friday 01 December and Saturday 02 December in Amsterdam. To find out more, please follow the link: bit.ly/47LrcZI #ESG #WomensHealth #estrogen #estetrol #biotech

Our team had productive visit to London for 4 intense days of conferences and events last week. It was great to connect with other industry leaders, investors and peers. Thank you to all those who made it happen! #WomensHealth #JefferiesHealthcare #ICRConsiliumHC #Lifescience

Mithra is dedicated to care, also beyond the advanced pharmaceuticals we develop. That is why our employees voluntarily donate blood to the Red Cross every year. This to contribute to a growing need to save lives! #giveblood #mithra

We are attending the 2023 @European Lifestars Awards this evening where we are shortlisted for the ‘Post-IPO Equity Raise of the Year’ award. We look forward to celebrating European life sciences alongside our fellow nominees and other guests. #EuropeanLifeStars #womenshealth

This week our Chief Executive Officer David Solomon and Head of Investor Relations Alex Sokolowski are in London. They will start the week at the @ConsiliumHC 11th Annual Healthcare Conference followed by @Jefferies Healthcare Conference. #ICRConsiliumHC #JefferiesHealthcare

David H. Solomon introduced Mithra’s capabilities and plans for growth to regional business leaders during a meeting of the Cercle de Wallonie on Tuesday. He took the opportunity to discuss the company’s operations and his views on the future of biotech at the event.

We are proud to announce that Mithra’s NEXTSTELLIS® has been granted an additional patent in the United States. More information can be found in our latest Press Release bit.ly/3MxhFgD

Our new Head of Investor Relations, Alex Sokolowski will be joining our Chief Executive Officer David Solomon in London for the @Jefferies Healthcare Conference. #JefferiesHealthcare #WomensHealth

We are proud to announce that Mithra’s CDMO has been awarded the title of Made Different Ambassador under the "Future Industry by Digital Wallonia" project. For more information we invite you to view the video that was published in Le Soir Online: youtu.be/wfVn2oHutMc

Mithra is excited to be the Convention on Pharmaceutical Ingredients (CPHI) in Barcelona! We are here to meet with industry leaders, learn about new advancements, innovate, and collaborate.

Mithra and Searchlight Pharma are proud to announce the signing of the DONESTA® licensing agreement for Canada! Read more about it : bit.ly/471GRUj

Mithra announces it will receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement. Read the press release : bit.ly/48Z0Rc9

October marks the beginning of World Menopause Awareness Month to raise awareness of menopause and the support available to women to improve health and well-being and reduce the taboo that surrounds this critical phase of life. #WorldMenopauseMonth2023

We have been shortlisted for the @European Lifestars Awards for the Post-IPO Equity Raise of the Year. Good luck to all those shortlisted! #Mithra #WomensHealth #lifestarsawards

Mithra is attending the North American Menopause Society Annual Meeting in Philadelphia, USA from September 27-30. Please get in touch with our team there. #Lifescience #WomensHealth #NAMS #Menopause

Today is #WorldContraceptionDay We are committed to providing women with innovative, convenient and safer choices that will improve lives. Visit the Mithra website to learn more about our work and you can find out more about the #WCD2023 campaign here: mithra.com/en/

Today, Mithra announces its 2023 Half Year Results. ➡️ Read the press release sharing our financial and operational highlights: bit.ly/3BE4TGR ➡️ Webcast 26 september at 02:00 PM: channel.royalcast.com/landingpage/mi…